Our latest patent titled Imidazo-pyrazole carboxamide derivatives as anticancer agents and the synthesis is under national patenting process at the present. The international patent application has been initiated on May, 17 2019.

Summary: Novel compound and its derivatives bear advantageous properties for the use in the treatment of solid malignancies, breast, lung, melanoma, gliomas, and myeloproliferative further myelodysplastic neoplasms, acute myelogenous/myeloid leukemias and colon cancer via inducing differentiation and subsequent apoptosis of pre-matured myeloid leukemic cells or myeloid-derived suppressor cells and/or by direct effect on solid tumors.